InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Christian Waage, Director. Director active across 3 companies, notably Heron Therapeutics, INC.. Aggregated, 15 disclosures have been recorded. Breakdown: 2 buys · 8 sells. Total volume traded: €183k. History available since 21 June 2021. The latest transaction was disclosed on 31 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
17,950 shares0Common StockSEC:0000950170-25-013728:0
17,950 shares0Common StockSEC:0000950170-25-012094:0
6,430 shares@ US$1.15553.7% of flowCommon StockSEC:0001728117-24-000041:0
13,948 shares0Common StockSEC:0001209191-24-001982:0
13,504 shares@ US$1.8211.9% of flowCommon StockSEC:0001728117-23-000098:0
18,500 shares@ US$1.19711.1% of flowCommon StockSEC:0001728117-23-000022:0
Ideal exit: 15 Dec 2023 (T+270)
38,580 shares0Common StockSEC:0001209191-22-062192:0
6,934 shares@ US$7.2126.8% of flowCommon StockSEC:0001728117-22-000063:0
Ideal exit: 11 Apr 2023 (T+270)
10,722 shares@ US$8.9150.11% mcap100.0% of flowCommon StockSEC:0001728117-22-000033:0
300 shares@ US$9.73450.0011% mcap13.5% of flowCommon StockSEC:0001209191-21-071172:0
300 shares@ US$9.734513.5% of flowCommon StockSEC:0001209191-21-071172
300 shares@ US$12.306516.5% of flowCommon StockSEC:0001209191-21-057420
300 shares@ US$12.30650.0013% mcap16.5% of flowCommon StockSEC:0001209191-21-057420:0
300 shares@ US$15.197320.0% of flowCommon StockSEC:0001209191-21-042433
300 shares@ US$15.19730.0016% mcap20.0% of flowCommon StockSEC:0001209191-21-042433:0
15 of 15 declarations
About Christian Waage
Christian Waage is a Board Member and EVP of Technical Operations and Administration at Heron Therapeutics, Inc. and Gossamer Bio, Inc. He brings essential technical and operational expertise to the leadership of these companies.
